The drug-device interface

Area of Science:

• Regulatory Science
• Pharmaceutical Science
• Medical Device Regulation

Background:

• The classification of medical products as either drugs or devices is not always straightforward.
• Certain products combine characteristics of both drugs and devices, creating regulatory ambiguity.

Purpose of the Study:

• To clarify the regulatory definition of a medical device that incorporates or administers a drug.
• To provide guidance on the classification of combination products under European Community (EC) Directives.

Main Methods:

• Analysis of relevant European Community Directives for medicinal products and medical devices.
• Comparative review of regulatory criteria for drug and device classification.
• Examination of case examples illustrating the drug-device distinction.

Main Results:

• The study identifies key criteria that determine the classification of combination products.
• It highlights the primary mode of action as a critical factor in classification.
• The article delineates the regulatory pathways for products incorporating or administering drugs.

Conclusions:

• Clear definitions are essential for the accurate classification of drug-device combination products.
• Adherence to EC Directives ensures appropriate regulatory oversight.
• Understanding these distinctions is crucial for manufacturers and regulatory bodies.